Current Psychopharmacology
Volume 9, 3 Issues, 2020
ISSN: 2211-5579 (Online)
ISSN: 2211-5560 (Print)
This journal supports open access
ISSN: 2211-5579 (Online)
ISSN: 2211-5560 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Psychopharmacology, Volume 4 - Number 2
Meet Our Editorial Board Member
, 4(2): 67Darakhshan Jabeen Haleem
DOI: 10.2174/221155600402160201130839
Editorial
Editorial (Thematic Issue:Classic and New Agents to the Treatment of Affective Disorders: Some Concerns and Perspectives
, 4(2): 68 - 69Mónica Flores-Ramos and Claudia Becerra-Palars
DOI: 10.2174/221155600402160201131634
Use of Dopaminergic Agents in the Treatment-Resistant Depression
, 4(2): 70 - 75Lorena Rodríguez-Bores, Mónica Flores-Ramos and Rafael Campuzano
DOI: 10.2174/2211556004666151008214105
Use of Dopaminergic Agents in the Treatment-Resistant Depression
Mechanism of Action and Potential Use of Tamoxifen in the Treatment of Acute Mania
, 4(2): 76 - 83Ledezma-Acevedo Jessica, Flores-Ramos Mónica, Carvajal-Lohr Armando and Becerra-Palars Claudia
DOI: 10.2174/2211556004666151008214355
Mechanism of Action and Potential Use of Tamoxifen in the Treatment of Acute Mania
Agomelatine for Bipolar Depression: A Chronotherapeutic Agent?
, 4(2): 84 - 95María Yoldi-Negrete, Claudia Becerra-Palars, Armando Carvajal-Lohr, Alejandra Monserrat Rodríguez-Ramírez and María Alejandra Martín-Manzo
DOI: 10.2174/2211556004666151008215220
Agomelatine for Bipolar Depression: A Chronotherapeutic Agent?
Neuroprotective Effects of Lithium in Patients with Bipolar Disorder
, 4(2): 96 - 102Claudia Becerra-Palars, Javier Amado-Lerma, Alejandra Andrade, Rafael Campuzano and Emilio Montemayor
DOI: 10.2174/2211556005666151216225423
Neuroprotective Effects of Lithium in Patients with Bipolar Disorder
The Use of Quetiapine for Comorbid Bipolar and Obsessive Compulsive Disorders
, 4(2): 103 - 111María Yoldi-Negrete, Mónica Flores-Ramos, Alejandra Montserrat Rodríguez-Ramírez, Carvajal-Lohr Armando, Jorge Ávila-Solorio, Martin-Manzo María Alejandra, Andrade Alejandra and Leonardo González-Flores
DOI: 10.2174/2211556005666151216224828
The Use of Quetiapine for Comorbid Bipolar and Obsessive Compulsive Disorders
Geriatric Psychopharmacology in Acute Settings
, 4(2): 112 - 118Andreea L. Seritan and Stefan Seritan
DOI: 10.2174/221155600402160201125256
Geriatric Psychopharmacology in Acute Settings
Teratogenic Potential of Atypical Antipsychotic Drugs, Quetiapine and Aripiprazole in Rats
, 4(2): 119 - 124Krishna Pal Singh and Nidhi Tripathi
DOI: 10.2174/221155600402160201125625
Teratogenic Potential of Atypical Antipsychotic Drugs, Quetiapine and Aripiprazole in Rats
High Fat Diet-Induced Obesity Stimulate Depressive Behavior in Rats
, 4(2): 125 - 132Hamna Rafiq and Muhammad Farhan
DOI: 10.2174/2211556005666151216225040
High Fat Diet-Induced Obesity Stimulate Depressive Behavior in Rats
Editor-in-Chief
Kenneth Blum
Western University of Health Sciences
Pomona, CA
(USA)
Biography
Western University of Health Sciences
Pomona, CA
Biography
Biography of Kenneth Blum
Dr. Blum serves as Chairman of Geneus Sciences LLC., His concept of Reward Deficiency Syndrome is
being embraced by world leaders in science and is part of the DSM –V, ASAM, Sage Encyclopedia of abnormal and clinical psychology 2017. Dr, Blum is credited with the DRD2 gene discovery and addictive diseases. He
serves as Editor-in-Chief in Journal of Reward Deficiency Syndrome (he coined) and Addiction Sciences
and Co-EIC of Journal of Neuroimaging in Psychiatry and Neurology (USG). He is currently serving on
fourteen other prestigious journal’s Editorial Boards. He has published over 450 articles, 16 books,
numerous patents and received many awards (Life-Time Achievements) for his seminal discoveries. He is
the founding President of United Scientific Group (USG).
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Psychopharmacology was launched in 2012. Dr. Kenneth Blum serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net